Hoth Therapeutics, a biotechnology company, has decided to invest $1 million into Bitcoin, marking a significant move in corporate treasury management. This decision underscores the increasing trend among businesses to adopt Bitcoin as a hedge against inflation.

The move by Hoth Therapeutics reflects a broader acceptance and recognition of Bitcoin’s potential as a store of value, especially in uncertain economic times.

This investment decision indicates growing confidence in Bitcoin's long-term value proposition, as more companies explore diversifying their treasury assets with cryptocurrency.